3-Iodobenzylguanidine
The therapeutic efficacy of Iobenguane can be decreased when used in combination with Amitriptyline.
4-Hydroxybutyric Acid
The risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Amitriptyline.
Abiraterone
The serum concentration of Amitriptyline can be increased when it is combined with Abiraterone.
Advertisement
Acenocoumarol
Amitriptyline may increase the anticoagulant activities of Acenocoumarol.
Acepromazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Acepromazine.
Aceprometazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Aceprometazine.
Advertisement
Acetophenazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Acetophenazine.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Amitriptyline.
Albuterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salbutamol.
Advertisement
Alfaxalone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Alfaxalone.
Alfentanil
The risk or severity of adverse effects can be increased when Alfentanil is combined with Amitriptyline.
Almotriptan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Almotriptan.
Alogliptin
The serum concentration of Amitriptyline can be increased when it is combined with Alogliptin.
alpha 1-Antitrypsin
The serum concentration of Amitriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alpha 1-Proteinase Inhibitor, Human
The serum concentration of Amitriptyline can be increased when it is combined with Alpha-1-proteinase inhibitor.
Alphaprodine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Alphaprodine.
Alprazolam
The risk or severity of adverse effects can be increased when Alprazolam is combined with Amitriptyline.
Altretamine
Altretamine may increase the orthostatic hypotensive activities of Amitriptyline.
Amiodarone
The metabolism of Amitriptyline can be decreased when combined with Amiodarone.
Amisulpride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Amisulpride.
Amobarbital
The metabolism of Amitriptyline can be increased when combined with Amobarbital.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Amitriptyline.
Amoxapine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Amoxapine.
Amphetamine
Amitriptyline may increase the stimulatory activities of Amphetamine.
Amprenavir
The serum concentration of Amitriptyline can be increased when it is combined with Amprenavir.
Anagrelide
Amitriptyline may increase the QTc-prolonging activities of Anagrelide.
Antithrombin III
The serum concentration of Amitriptyline can be increased when it is combined with Antithrombin III human.
Antithrombin III, Human
The serum concentration of Amitriptyline can be increased when it is combined with Antithrombin III human.
Apalutamide
The serum concentration of Amitriptyline can be decreased when it is combined with Apalutamide.
Apixaban
The serum concentration of Amitriptyline can be increased when it is combined with Apixaban.
Apomorphine
Amitriptyline may decrease the antihypertensive activities of Apomorphine.
Apraclonidine
Amitriptyline may decrease the antihypertensive activities of Apraclonidine.
Aprepitant
The serum concentration of Amitriptyline can be increased when it is combined with Aprepitant.
Aprotinin
The serum concentration of Amitriptyline can be increased when it is combined with Aprotinin.
Arbutamine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Arbutamine.
Arformoterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Arformoterol.
Argatroban
The serum concentration of Amitriptyline can be increased when it is combined with Argatroban.
Argatroban Anhydrous
The serum concentration of Amitriptyline can be increased when it is combined with Argatroban.
Aripiprazole
The risk or severity of adverse effects can be increased when Aripiprazole is combined with Amitriptyline.
Armodafinil
The metabolism of Amitriptyline can be decreased when combined with Armodafinil.
Arsenic Trioxide
Amitriptyline may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Amitriptyline may increase the QTc-prolonging activities of Artemether.
Articaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Articaine.
Asenapine
Amitriptyline may increase the QTc-prolonging activities of Asenapine.
Asunaprevir
The serum concentration of Amitriptyline can be increased when it is combined with Asunaprevir.
Atazanavir
The metabolism of Amitriptyline can be decreased when combined with Atazanavir.
Atomoxetine
The metabolism of Amitriptyline can be decreased when combined with Atomoxetine.
Azelastine
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Azelastine.
Azithromycin
The metabolism of Amitriptyline can be decreased when combined with Azithromycin.
Baclofen
The risk or severity of adverse effects can be increased when Baclofen is combined with Amitriptyline.
Bambuterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bambuterol.
Barbexaclone
The metabolism of Amitriptyline can be increased when combined with Barbexaclone.
Barbital
The metabolism of Amitriptyline can be increased when combined with Barbital.
Bedaquiline
Amitriptyline may increase the QTc-prolonging activities of Bedaquiline.
Benazepril
The serum concentration of Amitriptyline can be increased when it is combined with Benazepril.
Benoxinate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxybuprocaine.
Benperidol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benperidol.
Benzocaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzocaine.
Benzphetamine
Amitriptyline may decrease the antihypertensive activities of Benzphetamine.
Benzyl Alcohol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Benzyl alcohol.
Betaxolol
The metabolism of Amitriptyline can be decreased when combined with Betaxolol.
Bethanidine
Amitriptyline may decrease the antihypertensive activities of Bethanidine.
Bivalirudin
The serum concentration of Amitriptyline can be increased when it is combined with Bivalirudin.
Boceprevir
The metabolism of Amitriptyline can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Amitriptyline can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Amitriptyline can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Amitriptyline.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Amitriptyline.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Amitriptyline.
Brexpiprazole
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brexpiprazole.
Brimonidine
Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Bromazepam
The risk or severity of adverse effects can be increased when Bromazepam is combined with Amitriptyline.
Bromocriptine
Amitriptyline may decrease the antihypertensive activities of Bromocriptine.
Bromperidol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bromperidol.
Brompheniramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brompheniramine.
Brotizolam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Brotizolam.
Bupivacaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Bupivacaine.
Buprenorphine
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.
Bupropion
The metabolism of Amitriptyline can be decreased when combined with Bupropion.
Buspirone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Buspirone.
Butabarbital
The risk or severity of adverse effects can be increased when Butabarbital is combined with Amitriptyline.
Butalbital
The risk or severity of adverse effects can be increased when Butalbital is combined with Amitriptyline.
Butamben
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Butamben.
Butobarbital
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Butethal.
Butorphanol
The risk or severity of adverse effects can be increased when Butorphanol is combined with Amitriptyline.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Amitriptyline.
Caffeine
The metabolism of Amitriptyline can be decreased when combined with Caffeine.
Capecitabine
The metabolism of Amitriptyline can be decreased when combined with Capecitabine.
Captopril
The serum concentration of Amitriptyline can be increased when it is combined with Captopril.
Carbamazepine
The metabolism of Amitriptyline can be increased when combined with Carbamazepine.
Carbinoxamine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Carbinoxamine.
Cariprazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cariprazine.
Carisoprodol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Carisoprodol.
Celecoxib
The metabolism of Amitriptyline can be decreased when combined with Celecoxib.
Celiprolol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Celiprolol.
Ceritinib
The serum concentration of Amitriptyline can be increased when it is combined with Ceritinib.
Cetirizine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cetirizine.
Chloral Hydrate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chloral hydrate.
Chloramphenicol
The metabolism of Amitriptyline can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Amitriptyline.
Chlormethiazole
The risk or severity of adverse effects can be increased when Amitriptyline is combined with clomethiazole.
Chlormezanone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlormezanone.
Chloroprocaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chloroprocaine.
Chloroquine
The metabolism of Amitriptyline can be decreased when combined with Chloroquine.
Chlorpheniramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorphenamine.
CHLORPHENIRAMINE POLISTIREX
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorphenamine.
Chlorpromazine
The metabolism of Amitriptyline can be decreased when combined with Chlorpromazine.
Chlorprothixene
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorprothixene.
Chlorzoxazone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Chlorzoxazone.
Cholecalciferol
The metabolism of Amitriptyline can be decreased when combined with Cholecalciferol.
Cholesterol
The serum concentration of Amitriptyline can be increased when it is combined with Cholesterol.
Cilastatin
The serum concentration of Amitriptyline can be increased when it is combined with Cilastatin.
Cilazapril
The serum concentration of Amitriptyline can be increased when it is combined with Cilazapril.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Amitriptyline.
Cimetidine
The metabolism of Amitriptyline can be decreased when combined with Cimetidine.
Cinacalcet
The serum concentration of Amitriptyline can be increased when it is combined with Cinacalcet.
Ciprofloxacin
Amitriptyline may increase the QTc-prolonging activities of Ciprofloxacin.
Cisapride
Amitriptyline may increase the arrhythmogenic activities of Cisapride.
Citalopram
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Citalopram.
Clarithromycin
The metabolism of Amitriptyline can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Amitriptyline can be decreased when combined with Clemastine.
Clenbuterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clenbuterol.
Clidinium
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clidinium.
Clidinium bromide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clidinium.
Clobazam
The metabolism of Amitriptyline can be decreased when combined with Clobazam.
Clofezone
The metabolism of Amitriptyline can be decreased when combined with Rabeprazole.
Clomipramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clomipramine.
Clonazepam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Clonazepam.
Clonidine
Amitriptyline may decrease the antihypertensive activities of Clonidine.
Clopidogrel
The metabolism of Amitriptyline can be decreased when combined with Clopidogrel.
Clorazepate
The risk or severity of adverse effects can be increased when Clorazepate is combined with Amitriptyline.
CLORAZEPIC ACID
The risk or severity of adverse effects can be increased when Clorazepate is combined with Amitriptyline.
Clotrimazole
The metabolism of Amitriptyline can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Amitriptyline can be decreased when combined with Clozapine.
Cobicistat
The serum concentration of Amitriptyline can be increased when it is combined with Cobicistat.
Cocaine
The metabolism of Amitriptyline can be decreased when combined with Cocaine.
Codeine
The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Codeine is combined with Amitriptyline.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Amitriptyline.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Amitriptyline.
Crisaborole
The metabolism of Amitriptyline can be decreased when combined with Crisaborole.
Crizotinib
The metabolism of Amitriptyline can be decreased when combined with Crizotinib.
Cyamemazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyamemazine.
Cyclizine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyclizine.
Cyclobenzaprine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyclobenzaprine.
Cyclosporine
The metabolism of Amitriptyline can be decreased when combined with Cyclosporine.
Cyproheptadine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cyproheptadine.
Cyproterone Acetate
The serum concentration of Amitriptyline can be decreased when it is combined with Cyproterone acetate.
Dabigatran Etexilate
The serum concentration of the active metabolites of Dabigatran etexilate can be increased when Dabigatran etexilate is used in combination with Amitriptyline.
Dabrafenib
The serum concentration of Amitriptyline can be decreased when it is combined with Dabrafenib.
Dantrolene
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dantrolene.
Dapiprazole
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dapiprazole.
Darifenacin
The metabolism of Amitriptyline can be decreased when combined with Darifenacin.
Darunavir
The serum concentration of Amitriptyline can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Amitriptyline can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Amitriptyline can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Amitriptyline can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Amitriptyline can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Amitriptyline.
Desipramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desipramine.
Desloratadine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desloratadine.
Desmopressin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desmopressin.
Desvenlafaxine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Desvenlafaxine.
Dexbrompheniramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dexbrompheniramine.
Dexmedetomidine
Amitriptyline may decrease the antihypertensive activities of Dexmedetomidine.
Dexmethylphenidate
The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with Amitriptyline.
Dextroamphetamine
Amitriptyline may increase the stimulatory activities of Dextroamphetamine.
Dextromethorphan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromethorphan.
Dextromoramide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dezocine.
Diazepam
The risk or severity of adverse effects can be increased when Diazepam is combined with Amitriptyline.
Dibucaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Cinchocaine.
Dicumarol
Amitriptyline may increase the anticoagulant activities of Dicoumarol.
Diethylpropion
Amitriptyline may increase the stimulatory activities of Diethylpropion.
Difenoxin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Difenoxin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Amitriptyline.
Dihydroergotamine
Amitriptyline may decrease the antihypertensive activities of Dihydroergotamine.
Diltiazem
The metabolism of Amitriptyline can be decreased when combined with Diltiazem.
Dimenhydrinate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dimenhydrinate.
Diphenhydramine
The metabolism of Amitriptyline can be decreased when combined with Diphenhydramine.
Diphenoxylate
The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Amitriptyline.
Dipivefrin
Amitriptyline may decrease the antihypertensive activities of Dipivefrin.
Disopyramide
Amitriptyline may increase the QTc-prolonging activities of Disopyramide.
Dobutamine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dobutamine.
Dofetilide
Amitriptyline may increase the QTc-prolonging activities of Dofetilide.
Dolasetron
Amitriptyline may increase the QTc-prolonging activities of Dolasetron.
Domperidone
Amitriptyline may increase the QTc-prolonging activities of Domperidone.
Dothiepin
The metabolism of Amitriptyline can be decreased when combined with Dosulepin.
Doxepin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Doxepin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Amitriptyline.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Amitriptyline.
Doxycycline
The metabolism of Amitriptyline can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Amitriptyline can be decreased when combined with Doxycycline.
Doxylamine
Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Dronedarone
Amitriptyline may increase the QTc-prolonging activities of Dronedarone.
Droperidol
Droperidol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Droxidopa
Amitriptyline may decrease the antihypertensive activities of Droxidopa.
Duloxetine
Duloxetine may increase the serotonergic activities of Amitriptyline.
Dyclonine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dyclonine.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Amitriptyline.
Efavirenz
The metabolism of Amitriptyline can be decreased when combined with Efavirenz.
Eletriptan
The risk or severity of adverse effects can be increased when Eletriptan is combined with Amitriptyline.
Eliglustat
Amitriptyline may increase the QTc-prolonging activities of Eliglustat.
Enalapril
The serum concentration of Amitriptyline can be increased when it is combined with Enalapril.
Enalaprilat
The serum concentration of Amitriptyline can be increased when it is combined with Enalaprilat.
Enalaprilat Anhydrous
The serum concentration of Amitriptyline can be increased when it is combined with Enalaprilat.
Enflurane
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Enflurane.
Entacapone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Entacapone.
Enzalutamide
The serum concentration of Amitriptyline can be decreased when it is combined with Enzalutamide.
Epigallocatechin Gallate
The serum concentration of Amitriptyline can be increased when it is combined with Epigallocatechin Gallate.
Epinephrine
Amitriptyline may decrease the antihypertensive activities of Epinephrine.
ergoloid mesylates, USP
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ergoloid mesylate.
Ergonovine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ergonovine.
Ergotamine
Amitriptyline may decrease the antihypertensive activities of Ergotamine.
Erythromycin
The metabolism of Amitriptyline can be decreased when combined with Erythromycin.
Escitalopram
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Escitalopram.
Eslicarbazepine Acetate
The metabolism of Amitriptyline can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Amitriptyline can be decreased when combined with Esomeprazole.
Estazolam
The risk or severity of adverse effects can be increased when Estazolam is combined with Amitriptyline.
Eszopiclone
The risk or severity of adverse effects can be increased when Eszopiclone is combined with Amitriptyline.
Ethanol
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Ethanol.
Ethchlorvynol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethchlorvynol.
Ethosuximide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethosuximide.
Ethotoin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethotoin.
Ethyl Chloride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl chloride.
Ethyl Loflazepate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl loflazepate.
Ethylmorphine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethylmorphine.
Etidocaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Etidocaine.
Etifoxine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Etifoxine.
Etomidate
Amitriptyline may decrease the antihypertensive activities of Etomidate.
Etravirine
The metabolism of Amitriptyline can be decreased when combined with Etravirine.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Amitriptyline.
Ezogabine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ezogabine.
Felbamate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Felbamate.
Felodipine
The metabolism of Amitriptyline can be decreased when combined with Felodipine.
Fenoterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fenoterol.
Fentanyl
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fentanyl.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Amitriptyline.
Fexofenadine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fexofenadine.
Fibrinolysis Inhibitor
The serum concentration of Amitriptyline can be increased when it is combined with Aprotinin.
Flecainide
Amitriptyline may increase the QTc-prolonging activities of Flecainide.
Flibanserin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flibanserin.
Floxuridine
The metabolism of Amitriptyline can be decreased when combined with Floxuridine.
Fluconazole
Amitriptyline may increase the QTc-prolonging activities of Fluconazole.
Fluindione
Amitriptyline may increase the anticoagulant activities of Fluindione.
Flunarizine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flunarizine.
Flunitrazepam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Flunitrazepam.
Fluorouracil
The metabolism of Amitriptyline can be decreased when combined with Fluorouracil.
Fluoxetine
The risk or severity of adverse effects can be increased when Fluoxetine is combined with Amitriptyline.
Flupenthixol
Amitriptyline may increase the QTc-prolonging activities of Flupentixol.
Fluphenazine
The risk or severity of adverse effects can be increased when Fluphenazine is combined with Amitriptyline.
Flurazepam
The risk or severity of adverse effects can be increased when Flurazepam is combined with Amitriptyline.
Fluspirilene
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fluspirilene.
Fluticasone propionate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fluticasone propionate.
Fluvastatin
The metabolism of Amitriptyline can be decreased when combined with Fluvastatin.
Fluvoxamine
The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Amitriptyline.
Formoterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Formoterol.
Fosamprenavir
The serum concentration of Amitriptyline can be increased when it is combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Amitriptyline can be increased when it is combined with Fosaprepitant.
Fosinopril
The serum concentration of Amitriptyline can be increased when it is combined with Fosinopril.
Fosphenytoin
The metabolism of Amitriptyline can be increased when combined with Fosphenytoin.
Fospropofol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Fospropofol.
Frovatriptan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Frovatriptan.
Furazolidone
Furazolidone may increase the serotonergic activities of Amitriptyline.
Fusidate
The serum concentration of Amitriptyline can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Amitriptyline can be increased when it is combined with Fusidic Acid.
Gabapentin
The risk or severity of adverse effects can be increased when Gabapentin is combined with Amitriptyline.
Gabapentin Enacarbil
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Gabapentin Enacarbil.
Gadobenate
Amitriptyline may increase the QTc-prolonging activities of Gadobenic acid.
Gemfibrozil
The metabolism of Amitriptyline can be decreased when combined with Gemfibrozil.
Gemifloxacin
Amitriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Gemifloxacin Mesylate
Amitriptyline may increase the QTc-prolonging activities of Gemifloxacin.
Glutethimide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Glutethimide.
Goserelin
Amitriptyline may increase the QTc-prolonging activities of Goserelin.
Granisetron
Amitriptyline may increase the QTc-prolonging activities of Granisetron.
Guanabenz
Amitriptyline may decrease the antihypertensive activities of Guanabenz.
Guanfacine
Amitriptyline may decrease the antihypertensive activities of Guanfacine.
Halazepam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Halazepam.
Haloperidol
The metabolism of Amitriptyline can be decreased when combined with Haloperidol.
Halothane
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Halothane.
Heroin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Heroin.
Hexobarbital
The metabolism of Amitriptyline can be increased when combined with Hexobarbital.
Hydrocodone
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
HYDROCODONE POLISTIREX
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Hydromorphone
The risk or severity of adverse effects can be increased when Hydromorphone is combined with Amitriptyline.
Hydroxyzine
Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Hypoxis hemerocallidea root extract
The metabolism of Amitriptyline can be increased when combined with St. John's Wort.
Ibutilide
Amitriptyline may increase the QTc-prolonging activities of Ibutilide.
Idelalisib
The metabolism of Amitriptyline can be decreased when combined with Idelalisib.
Iloperidone
Amitriptyline may increase the QTc-prolonging activities of Iloperidone.
Imatinib
The metabolism of Amitriptyline can be decreased when combined with Imatinib.
Imidapril
The serum concentration of Amitriptyline can be increased when it is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Imipramine.
Indacaterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Indacaterol.
Indinavir
The metabolism of Amitriptyline can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Amitriptyline can be decreased when combined with Indinavir.
Iproniazid
Iproniazid may increase the serotonergic activities of Amitriptyline.
Irbesartan
The metabolism of Amitriptyline can be decreased when combined with Irbesartan.
Isavuconazole
The serum concentration of Amitriptyline can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Amitriptyline can be decreased when combined with Isavuconazonium.
Isocarboxazid
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Isocarboxazid.
Isoetharine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoetarine.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Amitriptyline.
Isoflurophate
The serum concentration of Amitriptyline can be increased when it is combined with Isoflurophate.
Isoniazid
The metabolism of Amitriptyline can be decreased when combined with Isoniazid.
Isoproterenol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Isoprenaline.
Isradipine
The metabolism of Amitriptyline can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Amitriptyline can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Amitriptyline can be increased when it is combined with Ivacaftor.
Ixazomib
The serum concentration of Amitriptyline can be increased when it is combined with Ixazomib.
Ketamine
The risk or severity of adverse effects can be increased when Ketamine is combined with Amitriptyline.
Ketazolam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ketazolam.
Ketoconazole
The metabolism of Amitriptyline can be decreased when combined with Ketoconazole.
Lamotrigine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lamotrigine.
Lapatinib
The metabolism of Amitriptyline can be decreased when combined with Lapatinib.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Amitriptyline.
Leflunomide
The metabolism of Amitriptyline can be decreased when combined with Leflunomide.
Lenvatinib
Amitriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lenvatinib Mesylate
Amitriptyline may increase the QTc-prolonging activities of Lenvatinib.
Lepirudin
The serum concentration of Amitriptyline can be increased when it is combined with Lepirudin.
Leuprolide
Amitriptyline may increase the QTc-prolonging activities of Leuprolide.
Levalbuterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levosalbutamol.
Levetiracetam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levetiracetam.
Levobupivacaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levobupivacaine.
Levocabastine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocabastine.
Levocetirizine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levocetirizine.
Levodopa
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levodopa.
Levofloxacin
Amitriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levofloxacin Anhydrous
Amitriptyline may increase the QTc-prolonging activities of Levofloxacin.
Levomethadyl
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levomethadyl Acetate.
Levomilnacipran
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Levomilnacipran.
Levonordefrin
Amitriptyline may decrease the antihypertensive activities of Levonordefrin.
Levorphanol
The risk or severity of adverse effects can be increased when Levorphanol is combined with Amitriptyline.
Levothyroxine
Levothyroxine may increase the arrhythmogenic activities of Amitriptyline.
Lidocaine
The metabolism of Amitriptyline can be decreased when combined with Lidocaine.
Linagliptin
The serum concentration of Amitriptyline can be increased when it is combined with Linagliptin.
Linezolid
Linezolid may increase the serotonergic activities of Amitriptyline.
Liothyronine
Liothyronine may increase the arrhythmogenic activities of Amitriptyline.
Lisdexamfetamine
Amitriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisdexamfetamine Dimesylate
Amitriptyline may increase the stimulatory activities of Lisdexamfetamine.
Lisinopril
The serum concentration of Amitriptyline can be increased when it is combined with Lisinopril.
Lisinopril Anhydrous
The serum concentration of Amitriptyline can be increased when it is combined with Lisinopril.
Lithium
Lithium may increase the neurotoxic activities of Amitriptyline.
Lithium Cation
Lithium may increase the neurotoxic activities of Amitriptyline.
Lofexidine
Amitriptyline may decrease the antihypertensive activities of Lofexidine.
Lopinavir
The metabolism of Amitriptyline can be decreased when combined with Lopinavir.
Loratadine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Loratadine.
Lorazepam
The risk or severity of adverse effects can be increased when Lorazepam is combined with Amitriptyline.
Lorcaserin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lorcaserin.
Lormetazepam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Lormetazepam.
Losartan
The metabolism of Amitriptyline can be decreased when combined with Losartan.
Lovastatin
The metabolism of Amitriptyline can be decreased when combined with Lovastatin.
Loxapine
The risk or severity of adverse effects can be increased when Loxapine is combined with Amitriptyline.
Luliconazole
The serum concentration of Amitriptyline can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of Amitriptyline can be increased when it is combined with Lumacaftor.
Lumefantrine
Amitriptyline may increase the QTc-prolonging activities of Lumefantrine.
Lurasidone
The risk or severity of adverse effects can be increased when Lurasidone is combined with Amitriptyline.
Magnesium Sulfate
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.
MAGNESIUM SULFATE ANHYDROUS
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Magnesium sulfate.
Manidipine
The metabolism of Amitriptyline can be decreased when combined with Manidipine.
Maprotiline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Maprotiline.
Meclizine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Meclizine.
Melatonin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Melatonin.
Meperidine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pethidine.
Mephentermine
Amitriptyline may increase the vasopressor activities of Mephentermine.
Mephobarbital
The metabolism of Amitriptyline can be increased when combined with Methylphenobarbital.
Mepivacaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Mepivacaine.
Meprobamate
The risk or severity of adverse effects can be increased when Meprobamate is combined with Amitriptyline.
Mesoridazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Mesoridazine.
Metaproterenol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Orciprenaline.
Metaraminol
Amitriptyline may increase the vasopressor activities of Metaraminol.
Metaxalone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Metaxalone.
Methadone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methadyl Acetate.
Methamphetamine
Amitriptyline may decrease the antihypertensive activities of Methamphetamine.
Methapyrilene
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methapyrilene.
Methaqualone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methaqualone.
Methocarbamol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methocarbamol.
Methohexital
The metabolism of Amitriptyline can be increased when combined with Methohexital.
Methotrimeprazine
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Methoxamine
Amitriptyline may increase the vasopressor activities of Methoxamine.
Methoxyflurane
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methoxyflurane.
Methsuximide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Methsuximide.
Methylene blue
Amitriptyline may increase the serotonergic activities of Methylene blue.
Methylphenidate
The risk or severity of adverse effects can be increased when Methylphenidate is combined with Amitriptyline.
Metoclopramide
The risk or severity of adverse effects can be increased when Metoclopramide is combined with Amitriptyline.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Amitriptyline.
Metylperon
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Melperone.
Metyrosine
The risk or severity of adverse effects can be increased when Metyrosine is combined with Amitriptyline.
Mexiletine
The metabolism of Amitriptyline can be decreased when combined with Mexiletine.
Midazolam
The risk or severity of adverse effects can be increased when Midazolam is combined with Amitriptyline.
Midodrine
Amitriptyline may increase the vasopressor activities of Midodrine.
Midostaurin
The metabolism of Amitriptyline can be decreased when combined with Midostaurin.
Mifepristone
The serum concentration of Amitriptyline can be increased when it is combined with Mifepristone.
Milnacipran
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Milnacipran.
Minaprine
Minaprine may increase the serotonergic activities of Amitriptyline.
Minocycline
Minocycline may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Mirabegron
The metabolism of Amitriptyline can be decreased when combined with Mirabegron.
Mirtazapine
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.
Mitotane
The serum concentration of Amitriptyline can be decreased when it is combined with Mitotane.
Moclobemide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Moclobemide.
Modafinil
The metabolism of Amitriptyline can be decreased when combined with Modafinil.
Moexipril
The serum concentration of Amitriptyline can be increased when it is combined with Moexipril.
Molindone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Molindone.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Amitriptyline.
Moxifloxacin
Amitriptyline may increase the QTc-prolonging activities of Moxifloxacin.
Moxonidine
The therapeutic efficacy of Moxonidine can be decreased when used in combination with Amitriptyline.
Nabilone
Nabilone may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Nalbuphine
The risk or severity of adverse effects can be increased when Nalbuphine is combined with Amitriptyline.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Amitriptyline.
Naphazoline
Amitriptyline may decrease the antihypertensive activities of Naphazoline.
Naratriptan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Naratriptan.
Nefazodone
The metabolism of Amitriptyline can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Amitriptyline can be decreased when combined with Nelfinavir.
Netupitant
The serum concentration of Amitriptyline can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Amitriptyline can be increased when combined with Nevirapine.
Nialamide
Nialamide may increase the serotonergic activities of Amitriptyline.
Nicardipine
The metabolism of Amitriptyline can be decreased when combined with Nicardipine.
Nicorandil
Amitriptyline may increase the hypotensive activities of Nicorandil.
Nicotine
The metabolism of Amitriptyline can be decreased when combined with Nicotine.
Nicotine Polacrilex
The metabolism of Amitriptyline can be decreased when combined with Nicotine.
Nilotinib
Amitriptyline may increase the QTc-prolonging activities of Nilotinib.
Nitrazepam
The risk or severity of adverse effects can be increased when Nitrazepam is combined with Amitriptyline.
Nitrous Oxide
The risk or severity of adverse effects can be increased when Nitrous oxide is combined with Amitriptyline.
Norepinephrine
Amitriptyline may decrease the antihypertensive activities of Norepinephrine.
Norflurane
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Norflurane.
Normethadone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Normethadone.
Nortriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Nortriptyline.
O-PHENANTHROLINE
The serum concentration of Amitriptyline can be increased when it is combined with 1,10-Phenanthroline.
Ofloxacin
Amitriptyline may increase the QTc-prolonging activities of Ofloxacin.
Olanzapine
The risk or severity of adverse effects can be increased when Olanzapine is combined with Amitriptyline.
Olaparib
The metabolism of Amitriptyline can be decreased when combined with Olaparib.
Olodaterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Olodaterol.
Olopatadine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Olopatadine.
Omeprazole
The metabolism of Amitriptyline can be decreased when combined with Omeprazole.
Ondansetron
Amitriptyline may increase the QTc-prolonging activities of Ondansetron.
Opium
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Opium.
Orphenadrine
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Osimertinib
The serum concentration of Amitriptyline can be increased when it is combined with Osimertinib.
Oxazepam
The risk or severity of adverse effects can be increased when Oxazepam is combined with Amitriptyline.
Oxprenolol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Oxprenolol.
Oxycodone
The risk or severity of adverse effects can be increased when Oxycodone is combined with Amitriptyline.
Oxymetazoline
Amitriptyline may decrease the antihypertensive activities of Oxymetazoline.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxymorphone is combined with Amitriptyline.
p-Hydroxyamphetamine
Amitriptyline may increase the stimulatory activities of Hydroxyamphetamine.
Palbociclib
The serum concentration of Amitriptyline can be increased when it is combined with Palbociclib.
Paliperidone
Amitriptyline may decrease the antihypertensive activities of Paliperidone.
Palonosetron
Palonosetron may increase the serotonergic activities of Amitriptyline.
Panobinostat
The serum concentration of Amitriptyline can be increased when it is combined with Panobinostat.
Pantoprazole
The metabolism of Amitriptyline can be decreased when combined with Pantoprazole.
Paraldehyde
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Amitriptyline.
Pargyline
Pargyline may increase the serotonergic activities of Amitriptyline.
Paroxetine
The risk or severity of adverse effects can be increased when Paroxetine is combined with Amitriptyline.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Amitriptyline.
Peginterferon Alfa-2b
The serum concentration of Amitriptyline can be decreased when it is combined with Peginterferon alfa-2b.
Pentamidine
Amitriptyline may increase the QTc-prolonging activities of Pentamidine.
Pentazocine
The risk or severity of adverse effects can be increased when Pentazocine is combined with Amitriptyline.
Pentobarbital
The metabolism of Amitriptyline can be increased when combined with Pentobarbital.
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Perazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Perazine.
Perflutren
Amitriptyline may increase the QTc-prolonging activities of Perflutren.
Pergolide
Amitriptyline may decrease the antihypertensive activities of Pergolide.
Periciazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Propericiazine.
Perindopril
The serum concentration of Amitriptyline can be increased when it is combined with Perindopril.
Perphenazine
The risk or severity of adverse effects can be increased when Perphenazine is combined with Amitriptyline.
Phenelzine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenelzine.
Phenindione
Amitriptyline may increase the anticoagulant activities of Phenindione.
Phenobarbital
The metabolism of Amitriptyline can be increased when combined with Phenobarbital.
Phenoxyethanol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenoxyethanol.
Phenprocoumon
Amitriptyline may increase the anticoagulant activities of Phenprocoumon.
Phentermine
Amitriptyline may increase the stimulatory activities of Phentermine.
PHENTERMINE RESIN
Amitriptyline may increase the stimulatory activities of Phentermine.
Phenylephrine
Amitriptyline may increase the vasopressor activities of Phenylephrine.
Phenylpropanolamine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Phenylpropanolamine.
Phenytoin
The metabolism of Amitriptyline can be increased when combined with Phenytoin.
Pimozide
Amitriptyline may increase the QTc-prolonging activities of Pimozide.
Pioglitazone
The metabolism of Amitriptyline can be decreased when combined with Pioglitazone.
Pipamperone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pipamperone.
Pipothiazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pipotiazine.
Pirbuterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pirbuterol.
Pirinitramide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Piritramide.
Pizotyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pizotifen.
Pomalidomide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pomalidomide.
Posaconazole
The metabolism of Amitriptyline can be decreased when combined with Posaconazole.
Pramipexole
Amitriptyline may increase the sedative activities of Pramipexole.
Pramoxine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Pramocaine.
Prazepam
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prazepam.
Pregabalin
The therapeutic efficacy of Amitriptyline can be increased when used in combination with Pregabalin.
Prilocaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prilocaine.
Primaquine
Amitriptyline may increase the QTc-prolonging activities of Primaquine.
Primidone
The metabolism of Amitriptyline can be increased when combined with Primidone.
Procainamide
Amitriptyline may increase the QTc-prolonging activities of Procainamide.
Procaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procaine.
Procarbazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procarbazine.
Procaterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Procaterol.
Prochlorperazine
The risk or severity of adverse effects can be increased when Prochlorperazine is combined with Amitriptyline.
Promazine
The metabolism of Amitriptyline can be decreased when combined with Promazine.
Promethazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Promethazine.
Propafenone
Amitriptyline may increase the QTc-prolonging activities of Propafenone.
Proparacaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Proparacaine.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Amitriptyline.
Propoxyphene
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Dextropropoxyphene.
Prothipendyl
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Prothipendyl.
Protriptyline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Protriptyline.
Pseudoephedrine
Amitriptyline may decrease the antihypertensive activities of Pseudoephedrine.
Pyrimethamine
The metabolism of Amitriptyline can be decreased when combined with Pyrimethamine.
Quazepam
The serum concentration of Amitriptyline can be increased when it is combined with Quazepam.
Quetiapine
Amitriptyline may increase the QTc-prolonging activities of Quetiapine.
Quetiapine fumarate
Amitriptyline may increase the QTc-prolonging activities of Quetiapine.
Quinapril
The serum concentration of Amitriptyline can be increased when it is combined with Quinapril.
Quinidine
Amitriptyline may increase the QTc-prolonging activities of Quinidine.
Quinine
Amitriptyline may increase the QTc-prolonging activities of Quinine.
Rabeprazole
The metabolism of Amitriptyline can be decreased when combined with Rabeprazole.
Racecadotril
The serum concentration of Amitriptyline can be increased when it is combined with Racecadotril.
Ramelteon
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ramelteon.
Ramipril
The serum concentration of Amitriptyline can be increased when it is combined with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Amitriptyline.
Rasagiline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rasagiline.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Amitriptyline.
Remoxipride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Remoxipride.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Amitriptyline.
Rifabutin
The metabolism of Amitriptyline can be increased when combined with Rifabutin.
Rifampin
The metabolism of Amitriptyline can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Amitriptyline can be increased when combined with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Amitriptyline.
Risperidone
Amitriptyline may decrease the antihypertensive activities of Risperidone.
Ritodrine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ritodrine.
Ritonavir
The metabolism of Amitriptyline can be decreased when combined with Ritonavir.
Rivaroxaban
The serum concentration of Amitriptyline can be increased when it is combined with Rivaroxaban.
Rizatriptan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Rizatriptan.
Rolapitant
The metabolism of Amitriptyline can be decreased when combined with Rolapitant.
Ropinirole
Amitriptyline may increase the sedative activities of Ropinirole.
Ropivacaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ropivacaine.
Rosiglitazone
The metabolism of Amitriptyline can be decreased when combined with Rosiglitazone.
Rotigotine
Amitriptyline may increase the sedative activities of Rotigotine.
Rucaparib
The metabolism of Amitriptyline can be decreased when combined with Rucaparib.
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Amitriptyline.
Salmeterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Salmeterol.
Saquinavir
The metabolism of Amitriptyline can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Amitriptyline can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Amitriptyline can be decreased when used in combination with Sarilumab.
Saxagliptin
The serum concentration of Amitriptyline can be increased when it is combined with Saxagliptin.
Saxagliptin Anhydrous
The serum concentration of Amitriptyline can be increased when it is combined with Saxagliptin.
Scopolamine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Scopolamine.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Scopolamine.
Secobarbital
The metabolism of Amitriptyline can be increased when combined with Secobarbital.
Selegiline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Selegiline.
Sertindole
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sertindole.
Sertraline
The risk or severity of adverse effects can be increased when Sertraline is combined with Amitriptyline.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Amitriptyline.
Sildenafil
The metabolism of Amitriptyline can be decreased when combined with Sildenafil.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Amitriptyline.
Siltuximab
The serum concentration of Amitriptyline can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Amitriptyline can be increased when it is combined with Simeprevir.
Sitagliptin
The serum concentration of Amitriptyline can be increased when it is combined with Sitagliptin.
Sitagliptin Phosphate
The serum concentration of Amitriptyline can be increased when it is combined with Sitagliptin.
Sodium Oxybate
Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Sodium Phosphate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.
Sodium Phosphate, Monobasic
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sodium phosphate.
Sorafenib
The metabolism of Amitriptyline can be decreased when combined with Sorafenib.
Sotalol
Amitriptyline may increase the QTc-prolonging activities of Sotalol.
Spirapril
The serum concentration of Amitriptyline can be increased when it is combined with Spirapril.
ST. JOHN'S WORT EXTRACT
The metabolism of Amitriptyline can be increased when combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Amitriptyline.
Sulfadiazine
The metabolism of Amitriptyline can be decreased when combined with Sulfadiazine.
Sulfamethoxazole
The metabolism of Amitriptyline can be decreased when combined with Sulfamethoxazole.
Sulfisoxazole
The metabolism of Amitriptyline can be decreased when combined with Sulfisoxazole.
Sulpiride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sulpiride.
Sumatriptan
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sumatriptan.
Sumatriptan Succinate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Sumatriptan.
Suvorexant
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Tamoxifen
The metabolism of Amitriptyline can be decreased when combined with Tamoxifen.
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Tasimelteon
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tasimelteon.
Tedizolid
Tedizolid Phosphate may increase the serotonergic activities of Amitriptyline.
Tedizolid Phosphate
Tedizolid Phosphate may increase the serotonergic activities of Amitriptyline.
Telaprevir
The metabolism of Amitriptyline can be decreased when combined with Telaprevir.
Telavancin
Amitriptyline may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Amitriptyline can be decreased when combined with Telithromycin.
Temazepam
The risk or severity of adverse effects can be increased when Temazepam is combined with Amitriptyline.
Tenofovir Disoproxil
The metabolism of Amitriptyline can be decreased when combined with Tenofovir disoproxil.
Terbinafine
The metabolism of Amitriptyline can be decreased when combined with Terbinafine.
Terbutaline
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.
Terbutaline Sulfate
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Terbutaline.
Teriflunomide
The serum concentration of Amitriptyline can be decreased when it is combined with Teriflunomide.
Tetrabenazine
Amitriptyline may increase the QTc-prolonging activities of Tetrabenazine.
Tetracaine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tetracaine.
Tetracaine hydrochloride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tetracaine.
Tetrahydrocannabinol
Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Thalidomide
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Theophylline
The metabolism of Amitriptyline can be decreased when combined with Theophylline.
Theophylline anhydrous
The metabolism of Amitriptyline can be decreased when combined with Theophylline.
Thiamylal
The metabolism of Amitriptyline can be increased when combined with Thiamylal.
Thiopental
The metabolism of Amitriptyline can be increased when combined with Thiopental.
Thiopental Sodium
The metabolism of Amitriptyline can be increased when combined with Thiopental.
Thioproperazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Thioproperazine.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Amitriptyline.
Thiotepa
The metabolism of Amitriptyline can be decreased when combined with Thiotepa.
Thiothixene
The risk or severity of adverse effects can be increased when Thiothixene is combined with Amitriptyline.
Thyroid, Porcine
Thyroid, porcine may increase the arrhythmogenic activities of Amitriptyline.
Tiagabine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tiagabine.
Tiapride
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tiapride.
Ticagrelor
The metabolism of Amitriptyline can be decreased when combined with Ticagrelor.
Ticlopidine
The metabolism of Amitriptyline can be decreased when combined with Ticlopidine.
Tipranavir
The metabolism of Amitriptyline can be decreased when combined with Tipranavir.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Amitriptyline.
Tocilizumab
The serum concentration of Amitriptyline can be decreased when it is combined with Tocilizumab.
Tolbutamide
The metabolism of Amitriptyline can be decreased when combined with Tolbutamide.
Tolcapone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tolcapone.
Toloxatone
Toloxatone may increase the serotonergic activities of Amitriptyline.
Topiramate
Topiramate may increase the central nervous system depressant (CNS depressant) activities of Amitriptyline.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Amitriptyline.
Toremifene
Amitriptyline may increase the QTc-prolonging activities of Toremifene.
Tramadol
Amitriptyline may increase the neuroexcitatory activities of Tramadol.
Trandolapril
The serum concentration of Amitriptyline can be increased when it is combined with Trandolapril.
Tranylcypromine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Tranylcypromine.
Trazodone
The risk or severity of adverse effects can be increased when Trazodone is combined with Amitriptyline.
Triazolam
The risk or severity of adverse effects can be increased when Triazolam is combined with Amitriptyline.
Triazulenone
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Loprazolam.
Trifluoperazine
The risk or severity of adverse effects can be increased when Trifluoperazine is combined with Amitriptyline.
Triflupromazine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Triflupromazine.
Trimethoprim
The metabolism of Amitriptyline can be decreased when combined with Trimethoprim.
Trimipramine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Trimipramine.
Triprolidine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Triprolidine.
Tropisetron
Tropisetron may increase the serotonergic activities of Amitriptyline.
Tryptophan
L-Tryptophan may increase the serotonergic activities of Amitriptyline.
Urethane
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ethyl carbamate.
Valproate
The serum concentration of Amitriptyline can be increased when it is combined with Valproic Acid.
Valproic Acid
The serum concentration of Amitriptyline can be increased when it is combined with Valproic Acid.
Valsartan
The metabolism of Amitriptyline can be decreased when combined with Valsartan.
Vandetanib
Amitriptyline may increase the QTc-prolonging activities of Vandetanib.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amitriptyline.
Venlafaxine
The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amitriptyline.
Verapamil
The metabolism of Amitriptyline can be decreased when combined with Verapamil.
Vigabatrin
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Vigabatrin.
Vilanterol
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Vilanterol.
Vilazodone
The risk or severity of adverse effects can be increased when Vilazodone is combined with Amitriptyline.
Vildagliptin
The serum concentration of Amitriptyline can be increased when it is combined with Vildagliptin.
Vincristine
The excretion of Vincristine can be decreased when combined with Amitriptyline.
Voriconazole
The metabolism of Amitriptyline can be decreased when combined with Voriconazole.
Vortioxetine
The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amitriptyline.
Warfarin
Amitriptyline may increase the anticoagulant activities of Warfarin.
Xylometazoline
Amitriptyline may decrease the antihypertensive activities of Xylometazoline.
Yohimbine
The serum concentration of Yohimbine can be increased when it is combined with Amitriptyline.
Zafirlukast
The metabolism of Amitriptyline can be decreased when combined with Zafirlukast.
Zaleplon
The risk or severity of adverse effects can be increased when Zaleplon is combined with Amitriptyline.
Ziconotide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Ziconotide.
Ziprasidone
Amitriptyline may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The serum concentration of Amitriptyline can be increased when it is combined with Zofenopril.
Zolmitriptan
The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amitriptyline.
Zolpidem
Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Zonisamide
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Zonisamide.
Zopiclone
The risk or severity of adverse effects can be increased when Zopiclone is combined with Amitriptyline.
Zotepine
The risk or severity of adverse effects can be increased when Amitriptyline is combined with Zotepine.
Zuclopenthixol
Amitriptyline may increase the QTc-prolonging activities of Zuclopenthixol.